In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

PAK4 inhibitor PF-03758309 
An orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PAK4 inhibitor PF-03758309 binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a variety of cancer cell types and plays an important role in cancer cell motility, proliferation, and survival. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonym:p21-activated kinase 4 inhibitor PF-03758309
Code name:PF-03758309